Exor NV
XMUN:EYX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Exor NV
XMUN:EYX
|
NL |
|
Sparebank 1 SR Bank ASA
F:B4M1
|
NO |
|
U
|
Unilever Indonesia Tbk PT
SWB:UTG
|
ID |
|
Sumuka Agro Industries Ltd
BSE:532070
|
IN |
|
Vireo Growth Inc
OTC:VREOF
|
US |
|
Derichebourg SA
F:PNU
|
FR |
|
P
|
PTC Inc
XMUN:PMTA
|
US |
|
Hong Leong Asia Ltd
SGX:H22
|
SG |
|
Grupo Aeroportuario del Pacifico SAB de CV
BMV:GAPB
|
MX |
Exor NV
Exor N.V. is a holding company, not a factory or a retailer. It owns stakes in businesses across cars, trucks, farm equipment, luxury goods, media, and healthcare, and it often takes a long-term role in those companies rather than trading in and out of them. Its best-known holdings have included major automotive and industrial companies, along with a few private businesses. Exor does not sell products directly to consumers. It makes money mainly from the companies it owns: dividends, gains when it sells investments, and sometimes income from businesses it fully owns or controls. For beginner investors, the key idea is that Exor is a portfolio owner that turns its capital into ownership stakes in operating businesses. What makes Exor different is that it acts as an active owner, not a passive fund. It often supports management, helps shape strategy, and holds positions for many years, especially in businesses where it sees room to build value over time. That gives it a role as a patient capital provider in industries that need strong long-term ownership.
Exor N.V. is a holding company, not a factory or a retailer. It owns stakes in businesses across cars, trucks, farm equipment, luxury goods, media, and healthcare, and it often takes a long-term role in those companies rather than trading in and out of them. Its best-known holdings have included major automotive and industrial companies, along with a few private businesses.
Exor does not sell products directly to consumers. It makes money mainly from the companies it owns: dividends, gains when it sells investments, and sometimes income from businesses it fully owns or controls. For beginner investors, the key idea is that Exor is a portfolio owner that turns its capital into ownership stakes in operating businesses.
What makes Exor different is that it acts as an active owner, not a passive fund. It often supports management, helps shape strategy, and holds positions for many years, especially in businesses where it sees room to build value over time. That gives it a role as a patient capital provider in industries that need strong long-term ownership.
NAV Outperformance: Exor's NAV per share outperformed the MSCI World Index by about 5%, largely due to a EUR 1 billion share buyback.
Lingotto Success: Lingotto delivered an 11% increase in performance, mainly from public investments, even as markets declined.
Ferrari Stake Monetization: Exor monetized EUR 3 billion of its Ferrari stake, maintaining significant investment firepower and reducing portfolio concentration.
Healthy Financial Position: The company reduced gross debt to EUR 3.5 billion and holds EUR 1.5 billion in cash, with a loan-to-value ratio now at 5.5%.
Active Portfolio Management: Exor invested EUR 1 billion in new opportunities, mainly Philips and bioMérieux, and realized EUR 3.5 billion in disposals.
No Sector Preference: Management stated there is no set priority for health care over luxury investments; each opportunity is evaluated on its merits.
Buyback Considerations: Buybacks remain part of the resource allocation process, but future actions depend on overall portfolio strategy.
Long-Term Approach: Exor reiterated commitment to long-term investments, notably in Ferrari and Philips, and does not plan to hedge FX or invest in crypto.
